Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01881074 · ClinicalTrials.gov registry record

Periodontal Treatment Response in Type II Diabetic Patients

A clinical trial, sponsored by University of Florida.

Completed
Registry status
74
Enrollment target

NCT01881074 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 74 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01881074 has completed, sponsored by University of Florida.

COMPLETED
Registry status
74 participants
Enrollment target

Study Summary

Diabetes mellitus affects \> 171 million people worldwide, with type II diabetes being the most prevalent, affecting 85-95% of the diabetic population. Unfortunately, despite conventional medical treatment, some diabetic patients do not seem to be able to reach desirable metabolic control. This is a double-blinded, randomized study investigating the effects of triclosan containing toothpaste (commercial name: Colgate Total) on the response to periodontal treatment in type II diabetic patients with periodontal disease. The investigators believe that using triclosan containing toothpaste during periodontal treatment will decrease the local inflammatory response and that this reduction will improve periodontal status and metabolic control.

Interventions

  • DRUG Triclosan containing toothpaste
  • DRUG Non-triclosan containing toothpaste

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2012-06
Est. Completion 2015-12

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01881074

The ClinicalTrials.gov registry entry for NCT01881074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Triclosan containing toothpaste is the first listed.

NCT01881074 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01881074 about?

NCT01881074 is a clinical study titled "Periodontal Treatment Response in Type II Diabetic Patients". Diabetes mellitus affects \> 171 million people worldwide, with type II diabetes being the most prevalent, affecting 85-95% of the diabetic population. Unfortunately, despite conventional medical treatment, some diabetic patients do not seem to be able to reach desirable metabolic control. This is a...

What is the current status of trial NCT01881074?

This trial is currently completed. The enrollment target is 74 participants. The study started on 2012-06. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01881074?

The interventions under investigation include: Triclosan containing toothpaste (DRUG), Non-triclosan containing toothpaste (DRUG).

Who is sponsoring clinical trial NCT01881074?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.